Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Inflammatory Markers in Huntington’s Disease Plasma – A Robust NanoLC-MRM-MS Assay Development

Rezeli, Melinda LU orcid ; Végvári, Ákos LU ; Silajdzic, Edina LU ; Björkqvist, Maria LU orcid ; Tabrizi, Sarah ; Laurell, Thomas LU and Marko-Varga, György LU (2014) In EuPA Open Proteomics 3. p.68-75
Abstract
The development of a quantitative multiplex reaction monitoring (MRM) assay is presented for the measurements of seven inflammatory markers in human plasma, using nanoLC-MS/MS analysis with stable isotope dilution strategy. We report a robust and sensitive, mass spectrometry based, quantitative assay with a relative standard deviation of <15% that accounts for the entire sample processing, while the analytical reproducibility of the assay was 3.6%. We used plasma from Huntington´s disease (HD) gene carriers and healthy controls to compare our MRM method with established antibody based methods. Interestingly, we found a good agreement between assays for the measurement of C-reactive protein (CRP).
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
multiple reaction monitoring, complement components, C-reactive protein, Huntington´s disease
in
EuPA Open Proteomics
volume
3
pages
68 - 75
publisher
Elsevier
external identifiers
  • scopus:84902440223
ISSN
2212-9685
DOI
10.1016/j.euprot.2014.02.003
language
English
LU publication?
yes
id
9cbc16b1-88d5-4ad8-b58e-9b38d282b6db (old id 4227339)
date added to LUP
2016-04-01 14:58:58
date last changed
2025-10-14 13:18:50
@article{9cbc16b1-88d5-4ad8-b58e-9b38d282b6db,
  abstract     = {{The development of a quantitative multiplex reaction monitoring (MRM) assay is presented for the measurements of seven inflammatory markers in human plasma, using nanoLC-MS/MS analysis with stable isotope dilution strategy. We report a robust and sensitive, mass spectrometry based, quantitative assay with a relative standard deviation of &lt;15% that accounts for the entire sample processing, while the analytical reproducibility of the assay was 3.6%. We used plasma from Huntington´s disease (HD) gene carriers and healthy controls to compare our MRM method with established antibody based methods. Interestingly, we found a good agreement between assays for the measurement of C-reactive protein (CRP).}},
  author       = {{Rezeli, Melinda and Végvári, Ákos and Silajdzic, Edina and Björkqvist, Maria and Tabrizi, Sarah and Laurell, Thomas and Marko-Varga, György}},
  issn         = {{2212-9685}},
  keywords     = {{multiple reaction monitoring; complement components; C-reactive protein; Huntington´s disease}},
  language     = {{eng}},
  pages        = {{68--75}},
  publisher    = {{Elsevier}},
  series       = {{EuPA Open Proteomics}},
  title        = {{Inflammatory Markers in Huntington’s Disease Plasma – A Robust NanoLC-MRM-MS Assay Development}},
  url          = {{http://dx.doi.org/10.1016/j.euprot.2014.02.003}},
  doi          = {{10.1016/j.euprot.2014.02.003}},
  volume       = {{3}},
  year         = {{2014}},
}